Profile | GDS5420 / 223809_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 31.63 | 25 |
GSM1296119 | B_lesional_pre-dose | 294.38 | 59 |
GSM1296076 | C_lesional_pre-dose | 249.45 | 57 |
GSM1296092 | D_lesional_pre-dose | 176.26 | 52 |
GSM1296103 | E_lesional_pre-dose | 53.96 | 33 |
GSM1296078 | F_lesional_pre-dose | 80.49 | 39 |
GSM1296107 | G_lesional_pre-dose | 92.9 | 38 |
GSM1296109 | H_lesional_pre-dose | 47.48 | 28 |
GSM1296080 | I_lesional_pre-dose | 33.67 | 27 |
GSM1296090 | J_lesional_pre-dose | 233.95 | 56 |
GSM1296074 | K_lesional_pre-dose | 273.68 | 59 |
GSM1296111 | L_lesional_pre-dose | 215.73 | 53 |
GSM1296099 | M_lesional_pre-dose | 93.11 | 40 |
GSM1296086 | O_lesional_pre-dose | 193.66 | 53 |
GSM1296117 | P_lesional_pre-dose | 209.27 | 52 |
GSM1296113 | Q_lesional_pre-dose | 281.29 | 57 |
GSM1296096 | R_lesional_pre-dose | 117.11 | 44 |
GSM1296105 | S_lesional_pre-dose | 39.69 | 27 |
GSM1296098 | T_lesional_pre-dose | 29.38 | 20 |
GSM1296101 | U_lesional_pre-dose | 113.68 | 43 |
GSM1296121 | V_lesional_pre-dose | 135.16 | 45 |
GSM1296088 | W_lesional_pre-dose | 75.01 | 38 |
GSM1296082 | X_lesional_pre-dose | 183.35 | 53 |
GSM1296115 | Y_lesional_pre-dose | 192.91 | 51 |
GSM1296084 | Z_lesional_pre-dose | 43.96 | 28 |
GSM1296072 | B_lesional_day8 | 247.81 | 55 |
GSM1296069 | L_lesional_day8 | 306.2 | 58 |
GSM1296071 | P_lesional_day8 | 314.39 | 59 |
GSM1296070 | Y_lesional_day8 | 223.76 | 53 |
GSM1296073 | V_lesional_day8 | 375.64 | 63 |
GSM1296034 | A_lesional_day15 | 39.83 | 26 |
GSM1296041 | G_lesional_day15 | 199.64 | 52 |
GSM1296035 | R_lesional_day15 | 240.88 | 55 |
GSM1296038 | U_lesional_day15 | 148.21 | 48 |
GSM1296047 | B_lesional_day15 | 164.26 | 48 |
GSM1296039 | E_lesional_day15 | 365.95 | 63 |
GSM1296042 | H_lesional_day15 | 167.47 | 48 |
GSM1296043 | L_lesional_day15 | 147.01 | 45 |
GSM1296037 | M_lesional_day15 | 58.28 | 32 |
GSM1296046 | P_lesional_day15 | 269.7 | 56 |
GSM1296044 | Q_lesional_day15 | 169.47 | 47 |
GSM1296045 | Y_lesional_day15 | 290.64 | 57 |
GSM1296025 | C_lesional_day15 | 12.41 | 11 |
GSM1296033 | D_lesional_day15 | 101.2 | 42 |
GSM1296027 | I_lesional_day15 | 84.86 | 41 |
GSM1296032 | J_lesional_day15 | 26.75 | 22 |
GSM1296024 | K_lesional_day15 | 103.56 | 43 |
GSM1296031 | W_lesional_day15 | 149.59 | 47 |
GSM1296028 | X_lesional_day15 | 70.54 | 37 |
GSM1296029 | Z_lesional_day15 | 121.04 | 45 |
GSM1296026 | F_lesional_day15 | 65.98 | 35 |
GSM1296030 | O_lesional_day15 | 123.44 | 47 |
GSM1296040 | S_lesional_day15 | 37.12 | 26 |
GSM1296036 | T_lesional_day15 | 32.26 | 23 |
GSM1296048 | V_lesional_day15 | 318.64 | 60 |
GSM1296059 | A_lesional_day43 | 51.48 | 32 |
GSM1296066 | G_lesional_day43 | 77.88 | 35 |
GSM1296060 | R_lesional_day43 | 218.66 | 54 |
GSM1296063 | U_lesional_day43 | 412.07 | 65 |
GSM1296064 | E_lesional_day43 | 193.23 | 53 |
GSM1296067 | H_lesional_day43 | 196.82 | 50 |
GSM1296062 | M_lesional_day43 | 81.45 | 38 |
GSM1296068 | Q_lesional_day43 | 128.6 | 42 |
GSM1296050 | C_lesional_day43 | 125.17 | 45 |
GSM1296057 | D_lesional_day43 | 127.18 | 45 |
GSM1296052 | I_lesional_day43 | 99.27 | 43 |
GSM1296054 | J_lesional_day43 | 51.71 | 31 |
GSM1296049 | K_lesional_day43 | 72.05 | 37 |
GSM1296055 | W_lesional_day43 | 177.78 | 49 |
GSM1296053 | X_lesional_day43 | 52.53 | 32 |
GSM1296058 | Z_lesional_day43 | 104.27 | 43 |
GSM1296051 | F_lesional_day43 | 132.59 | 47 |
GSM1296056 | O_lesional_day43 | 317.78 | 61 |
GSM1296065 | S_lesional_day43 | 95.84 | 40 |
GSM1296061 | T_lesional_day43 | 91.66 | 39 |
GSM1296095 | A_non-lesional_pre-dose | 133.32 | 47 |
GSM1296120 | B_non-lesional_pre-dose | 167.2 | 48 |
GSM1296077 | C_non-lesional_pre-dose | 46.22 | 31 |
GSM1296093 | D_non-lesional_pre-dose | ||
GSM1296104 | E_non-lesional_pre-dose | 111.62 | 43 |
GSM1296079 | F_non-lesional_pre-dose | 21.96 | 18 |
GSM1296108 | G_non-lesional_pre-dose | 76.85 | 36 |
GSM1296110 | H_non-lesional_pre-dose | 119.55 | 41 |
GSM1296081 | I_non-lesional_pre-dose | 4.6 | 5 |
GSM1296091 | J_non-lesional_pre-dose | 23.53 | 21 |
GSM1296075 | K_non-lesional_pre-dose | 103.75 | 43 |
GSM1296112 | L_non-lesional_pre-dose | 50.17 | 26 |
GSM1296100 | M_non-lesional_pre-dose | 33.07 | 25 |
GSM1296087 | O_non-lesional_pre-dose | 62.1 | 37 |
GSM1296118 | P_non-lesional_pre-dose | 49.7 | 27 |
GSM1296114 | Q_non-lesional_pre-dose | 168.98 | 48 |
GSM1296097 | R_non-lesional_pre-dose | 92.22 | 40 |
GSM1296106 | S_non-lesional_pre-dose | 57.51 | 32 |
GSM1296102 | U_non-lesional_pre-dose | 213.97 | 52 |
GSM1296122 | V_non-lesional_pre-dose | 113.76 | 41 |
GSM1296089 | W_non-lesional_pre-dose | 13.15 | 12 |
GSM1296083 | X_non-lesional_pre-dose | 89.74 | 40 |
GSM1296116 | Y_non-lesional_pre-dose | 50.26 | 26 |
GSM1296085 | Z_non-lesional_pre-dose | 17.54 | 16 |